[Federal Register Volume 70, Number 65 (Wednesday, April 6, 2005)]
[Notices]
[Pages 17470-17471]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-6794]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated September 16, 2004, and published in the Federal 
Register on September 30, 2004, (69 FR 58541), Aldrich Chemical Company 
Inc., DBA Isotec, 3858 Benner Road, Miamisburg, Ohio 45342-4304, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of the basic classes of controlled 
substances listed in Schedules I and II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Cathinone (1235)...........................  I
Methcathinone (1237).......................  I
N-Ethylamphetamine (1475)..................  I
N,N-Dimethylamphetamine (1480).............  I
Aminorex (1585)............................  I
Gamma hydroxybutyric acid (2010)...........  I
Methaqualone (2565)........................  I
Lysergic acid dethylamide (7315)...........  I
Tetrahydrocannabinols (7370)...............  I
Mescaline (7381)...........................  I
2,5-Dimethoxyamophetamine (7396)...........  I
3,4-Methylenedioxyamphetamine (7400).......  I
3,4-Methylenedioxy-N-ethylamphetamine        I
 (7404).
3,4-Methylenedioxy-methamphetamine (7405)..  I
4-Methoxyamphetamine (7411)................  I
Psilocybin (7437)..........................  I
Psilocyn (7438)............................  I
N-Ethyl-1-phenylcyclohexylamine (7455).....  I
Dihydromorphine (9145).....................  I
Normorphine (9313).........................  I
Acetylmethadol (9601)......................  I
Alphacetylmethadol Except Levo-              I
 Alphacetylmethadol (9603).
Normethadone (9635)........................  I
3-Methylfentanyl (9813)....................  I
Amphetamine (1100).........................  II
Methamphetamine (1105).....................  II
Methylphenidate (1724).....................  II
Amobarbital (2125).........................  II
Pentobarbital (2270).......................  II
Secobarbital (2315)........................  II
1-Phenylcyclohexylamine (7460).............  II
Phencyclidine (7471).......................  II
Phenylacetone (8501).......................  II
1-Piperidinocyclohexane-carbonitrile (8603)  II
Codeine (9050).............................  II
Dihydrocodeine (9120)......................  II
Oxycodone (9143)...........................  II
Hydromorphone (9150).......................  II
Benzoylecgonine (9180).....................  II
Ethylmorphine (9190).......................  II
Hydrocodone (9193).........................  II
Isomethadone (9226)........................  II
Meperidine (9230)..........................  II
Meperidine Intermediate-A (9232)...........  II
Merperidine Intermediate-B (9233)..........  II
Methadone (9250)...........................  II
Methadone Intermediate (9254)..............  II
Dextropropoxyphene, bulk, (non-dosage        II
 forms) (9273).
Levo-alphacetylmethadol (9648).............  II
Oxymorphone (9652).........................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The company plans to manufacture small quantities of the listed 
controlled substances to produce isotope labeled standards for drug 
analysis.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Aldrich Chemical Company, Inc. to manufacture the listed basic classes 
of controlled substances is consistent with

[[Page 17471]]

the public interest at this time. DEA has investigated Aldrich Chemical 
Company, Inc. to ensure that the company's registration is consistent 
with the public interest. The investigation has included inspection and 
testing of the company's physical security systems, verification of the 
company's compliance with state and local laws, and a review of the 
company's background and history. Therefore, pursuant to 21 U.S.C. 823, 
and in accordance with 21 CFR 1301.33, the above named company is 
granted registration as a bulk manufacturer of the basic classes of 
controlled substances listed.

    Dated: March 29, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 05-6794 Filed 4-5-05; 8:45 am]
BILLING CODE 4410-09-P